Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e9-e11. doi: 10.1016/j.clml.2018.10.002. Epub 2018 Oct 13.

Authors

Kristine A Frerichs¹, Patricia W C Bosman¹, Inger S Nijhof¹, Sonja Zweegman¹, Niels W C J van de Donk²

Affiliations

¹ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
² Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Electronic address: [email protected].

No abstract available

Keywords: CD38 antibodies; CMV; Infectious complication; Plasma cell dyscrasia; Viral infection.

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / pharmacology
Antibodies, Monoclonal / therapeutic use*
Cytomegalovirus / pathogenicity*
Female
Humans
Middle Aged
Multiple Myeloma / complications*
Multiple Myeloma / drug therapy*

Substances

Antibodies, Monoclonal
daratumumab